MedTrace Logo

Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia

NCT00300794 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2006-11-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether low-dose ketamine infusion is effective in suppressing the symptoms of opiate withdrawal during rapid opiate antagonist induction (RAI).

Conditions

  • Opiate Dependence

Interventions

DRUG

Ketamine

Sponsors & Collaborators

  • Vilnius University

    lead OTHER

Principal Investigators

  • Juozas Ivaskevicius, Prof. · Vilnius University Clinic of Anaesthesiology and Intensive Care

  • Tomas Jovaisa, MD · Vilnius University Clinic of Anaesthesiology and Intensive Care

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-02-28
Completion
2006-06-30

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00300794 on ClinicalTrials.gov